Showing results (161-170 of 291) with videos related to

Sort By:
Pageof 30
The Journal of Clinical Investigation|March 1, 1975
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiencyJ B Ziegler, C A Alper, R S Rosen, et al.
Allergy|October 1, 1994
The profiles of interleukin (IL)-2, IL-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic diseaseS M McHugh, A B Wilson, J Deighton, et al.
Immunology|May 1, 1992
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59M G Wing, J Zajicek, D J Seilly, et al.
European Journal of Immunology|June 1, 1985
Human clones with natural killer function can activate B cells and secrete B cell differentiation factorsA Vyakarnam, M K Brenner, J E Reittie, et al.
Biological Trace Element Research|November 23, 2013
Tissue-and metal-specific effects of thiolacrylic acids in ratsE Giroux, P J Lachmann, H G Petering, et al.
Clinical and Experimental Immunology|June 1, 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitroN Amos, J G Sissons, J F Girard, et al.
Clinical and Experimental Immunology|March 1, 1975
Immunoconglutinins and C3 in human salivaB D Williams, S J Challacombe, J M Slaney, et al.
Journal of Neuroimmunology|January 1, 1985
Immunological studies on the cerebrospinal fluid in neurological sarcoidosisJ D Mitchell, P L Yap, L A Milne, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1995
Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapyS M McHugh, J Deighton, A G Stewart, et al.
Clinical and Experimental Immunology|September 30, 2015
Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotypeP J Lachmann, E Lay, D J Seilly, et al.
Pageof 30